Estrogen and estrogen receptors in benign prostatic hyperplasia
Wu, J.-Q.; Gao, X.
Zhonghua Nan Ke Xue 8(3): 212-214
2002
ISSN/ISBN: 1009-3591 PMID: 12478848 Document Number: 542090
Estrogen is a strong growth regulator of the prostate stromal cells, it produces a marked effect by means of binding to specific receptors. Many researches have indicated that estrogen and estrogen receptors take part in the whole process and development of benign prostatic hyperplasia. This article gives a general description of the function of estrogen and estrogen receptors in benign prostatic hyperplasia.
Document emailed within 1 workday
Related Documents
Matsuda, T.; Abe, H.; Suda, K. 2004: Relation between benign prostatic hyperplasia and obesity and estrogen Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 291-294Yang, G.-Q.; Li, S.-W.; Zheng, H.; Zhang, W.-B.; Hu, W.-L.; Zheng, X.-M. 2009: Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis Zhonghua Nan Ke Xue 15(4): 314-317
Rockel, P.; Hoffmann, B.; Kyrein, H.J. 1978: Relationships between the size of ovarian follicles, the binding capacity of uterine estrogen receptors and estrogen concentrations in the follicular fluid and urine of calves under estrogen therapy Berliner und Munchener Tierarztliche Wochenschrift 91(24): 476-479
Blankenstein, M.A.; Mulder, E.; Broerse, J.J.; Van Der Molen, H.J. 1980: Mammary gland estrogen receptors and plasma prolactin during estrogen enhanced rat mammary tumor development strain difference in the response to estrogen Radiation and Environmental Biophysics 17(4): 359
Lang, J.H.; Zhu, L.; Sun, Z.J.; Chen, J. 2003: Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 80(1): 35-39
Imai, Y. 2013: Regulation of bone metabolisms by estrogen/estrogen receptors signaling Clinical Calcium 23(11): 1621-1626
Moise, M.; Răducan, S.; Boscu, A.; Jianu, A.; Niculescu, M.; Selaru, M.; Motoc, A. 2012: Immunohistochemical profile of the estrogen and progesterone receptors in mammary benign lesions Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(3): 875-882
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Chen, F.-P.; Hsu, T.; Hu, C.-H.; Wang, W.-D.; Wang, K.-C.; Teng, L.-F. 2004: Expression of estrogen receptors alpha and beta in human osteoblasts: identification of exon-2 deletion variant of estrogen receptor beta in postmenopausal women Chang Gung Medical Journal 27(2): 107-115
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Kletscher, B.A.; Oesterling, J.E. 1995: Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 423-430
Blanc, M.; Sacrini, A.; Avogadro, A.; Gattamorta, M.; Lazzerini, F.; Gattoni, F.; Cretti, F. 1998: Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia La Radiologia Medica 95(3): 182-187
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Kahán, Z. 1996: Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?) Orvosi Hetilap 137(42): 2305-2308
Maygarden, S.J.; Strom, S.; Ware, J.L. 1992: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia Archives of Pathology and Laboratory Medicine 116(3): 269-273
Zeng, X.; Yao, Z. 2003: Relationship between expression of somatostatin receptors subtype 2 mRNA and estrogen and progesterone receptors in breast cancer Chinese Medical Journal 116(12): 1850-1853